Ranbaxy Laboratories Limited
101
0
0
101
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 101 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 101 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (101)
Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions
Role: lead
Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions
Role: lead
Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions
Role: lead
Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions
Role: lead
Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions
Role: lead
Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions
Role: lead
Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions
Role: lead
Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions
Role: lead
Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study
Role: lead
Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study
Role: lead
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions
Role: lead
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
Role: lead
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
Role: lead
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
Role: lead
A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition
Role: lead
Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions
Role: lead
Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions
Role: lead
A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition
Role: lead
Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
Role: lead
A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition
Role: lead